Korean tech giants Samsung Electronics and SK hynix lead the global AI race but trade at roughly half the valuation of their U.S. rival Micron Technology, a senior executive at JP Morgan Asset Management said Tuesday.
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
Global investment banks estimate Korea’s economic growth will average 1.9 percent next year, down from the 2 percent projected in June, according to the Korea Center for International Finance on Monday.
JP Morgan Chase CEO Jamie Dimon met with heads of Korea's sovereign wealth fund and other major financial institutions to discuss investment opportunities and macroeconomic issues, sources said Monday.
Lotte Card, Korea's fifth largest card company, is up for sale for around three trillion won ($2.3 billion), according to local media reports on Wednesday.
Korea's central bank is expected to hike its key interest rate four more times by year's end considering its hawkish stance shown in the minutes of its latest rate-setting meeting, global investment bank JP Morgan said Wednesday.
Samsung Biologics will focus on scaling up its production and research sites for the coming decades with an aim of venturing into new drug formats like vaccines and developing new medication beyond its core biosimilar business.
Korea JoongAng Daily Sitemap
